Previous Article | Next Article 
Journal of Virology, September 2000, p. 7943-7951, Vol. 74, No. 17
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Poxvirus-Induced Immunostimulating Effects on Porcine
Leukocytes
Vicky
Fachinger,1
Tobias
Schlapp,2
Walter
Strube,2
Norbert
Schmeer,2 and
Armin
Saalmüller1,*
Institute of Immunology, Federal Research
Centre for Virus Diseases of Animals, D-72076
Tübingen,1 and R&D/BIO
Research, Bayer AG Animal Health, D-51368
Leverkusen,2 Germany
Received 15 February 2000/Accepted 26 May 2000
 |
ABSTRACT |
The prophylactic application of inactivated parapox ovis viruses
(Baypamun; Bayer AG, Leverkusen, Germany) has been shown to reduce
efficiently the outbreak of stress-mediated diseases in different
species. However, little is known about the basic mechanism behind this
observed stimulatory property. We therefore tested eight inactivated
poxvirus strains belonging to three different genera
(Orthopoxvirus, Avipoxvirus, and
Parapoxvirus) for their capacity to activate cells of the
porcine innate and specific immune systems in vitro. The results
indicated that poxviruses failed to induce increased phagocytosis,
oxidative burst, or natural killer cell activity in swine. In contrast,
enhanced release of interleukin-2, alpha interferon, and gamma
interferon, as well as strong proliferation, could be measured. Flow
cytometric analyses and cell sorting experiments identified T-helper
cells as the main target responding to inactivated poxviruses: the
activated cells had a CD4high CD25+ major
histocompatibility complex type II-positive phenotype and were the
major source of secreted cytokines. Together, the results demonstrated
that all tested poxviruses possessed immunostimulating capacity. These
in vitro poxvirus-induced effects may be responsible at least in part
for the in vivo immunostimulating capacity of inactivated poxviruses.
 |
INTRODUCTION |
The Poxviridae are the
largest of the known human and animal viruses (23). Due to
their complex genetic structure (2) and thereby their strong
immunogenic properties, poxviruses developed strategies of immune
evasion that are distinct from those of smaller viruses. Instead of
latency, slow replication, or high mutation rates (38),
poxviruses utilize a variety of genes encoding proteins that counteract
host immune responses. These viral proteins include soluble host growth
factor homologues (35) as well as soluble receptors for
tumor necrosis factor alpha (TNF-
) (36), interleukin-1
(IL-1
) (1), gamma interferon (IFN-
) (37),
alpha/beta interferon (IFN-
/
) (34), and various
chemokines (11). If the viruses fail to secrete these
proteins, as when the respective genes are deleted or the viruses are
inactivated, the strong immunogenicity of the viruses may induce host
immune reactions which are no longer inhibited (15, 25).
There is a growing evidence that such immune reactions may result in
more than elimination of the viruses. A more general stimulating effect
on the immune system may ensue.
In 1978, it was first noted that inactivated poxviruses may possess
immunostimulating capacity. Prophylactic application of parapox ovis
viruses (PPOV) or fowl poxviruses (FPV) that had been inactivated
(iPPOV and iFPV, respectively) clearly diminished the rate of mortality
of Pseudomonas aeruginosa-infected mice (21).
Subsequently, various in vitro experiments, mainly focusing on early
effects (before day 2), indicated that iFPV, iPPOV, and modified
vaccinia virus Ancara (MVA) that had been inactivated (iMVA) could
induce enhanced phagocytosis, natural killer (NK) cell activity, and
release of IFN-
(5, 10, 18). Moreover, the secretion of
TNF-
, IL-2, and granulocyte-macrophage colony-stimulating factor
could also be enhanced by iFPV and iPPOV (17, 19, 32). In
addition, several in vivo studies demonstrated that a prophylactic or
metaphylactic application of iPPOV (strain D1701; Baypamun; Bayer AG,
Leverkusen, Germany) efficiently reduced susceptibility to infectious
diseases in different species (6, 16, 33, 39).
The three viruses
MVA, PPOV, and FPV
that have been predominantly
analyzed for their immunostimulating capacity so far are (in part)
highly attenuated compared to the respective wild-type viruses
(20, 22). For example, MVA has lost about 15% of its original genetic information, including genes that encode host growth
factor homologues and soluble receptors for chemokines, TNF-
,
IFN-
, and IFN-
/
(2). Although iMVA, iPPOV, and iFPV belong to different genera (Orthopoxvirus,
Avipoxvirus, and Parapoxvirus), being
characterized by different morphological, chemical, and genetical
properties (23), immunostimulating capacity has been found
for all three. This finding suggests that the capacity to stimulate the
immune system is a general feature of poxviruses.
The aim of the present study was to characterize further the
poxvirus-induced immunostimulating effects. As a suitable model, pigs
offer several advantages in comparison to other species. Different in
vivo studies have indicated that iPPOV can stimulate the porcine immune
system. This virus may also be helpful in the prevention of
economically important stress-mediated diseases, such as mastitis
metritis agalactia syndrome (13), postweaning diarrhoea
syndrome (16), or wasting pig syndrome (16). In addition, in vitro studies have revealed that porcine peripheral blood
mononuclear cells (PBMC) respond to iFPV, iMVA, and iPPOV stimulation
with increased IFN-
and IL-2 release (5, 32). Our
intention was to examine further inducible effects within the innate
and specific immune systems. As markers for early immunological reactions, phagocytosis, oxidative burst, and NK cell activity were
chosen. Markers for late observable reactions were the quantification of proliferation and of IL-2, IFN-
, and IFN-
. The investigations began with characterization of the immunostimulating property of iPPOV,
because this virus is the best characterized in terms of in vivo and in
vitro immunostimulating capacities (13, 16, 32, 33). These
studies were then extended to other poxviruses to determine whether the
stimulating capacity is a common feature of poxviruses, even those
belonging to different genera. Together, these experiments should help
to elucidate the basic mechanisms responsible for the immunostimulating
capacity of inactivated poxviruses.
 |
MATERIALS AND METHODS |
Animals.
A total of 50 conventionally reared, healthy, 3- to
6-month-old German Landrace swine of both sexes, housed at the Federal Research Centre for Virus Diseases of Animals, were used for the experiments. With the exception of a prophylactic deworming (Citarin; Bayer AG), animals were not medically treated. They had no contact with
any poxviruses and were thus regarded as non-poxvirus-primed animals.
PBMC were isolated from heparinized blood (0.1 mg/ml) taken by anterior
vena cava puncture. PBMC from all 50 animals were tested for reactivity
to iPPOV in proliferation assays; PBMC from 10 animals were used for
other experiments.
Cells.
PBMC were isolated by Ficoll-Hypaque density gradient
centrifugation and cultured in RPMI 1640 medium supplemented with 10% (vol/vol) fetal calf serum, 2 mM L-glutamine, 100 IU of
penicillin per ml, 0.1 mg of streptomycin sulfate per ml, and 0.05 mM
mercaptoethanol. The medium for the murine IL-2-dependent cell line
HT-2 (American Type Culture Collection [ATCC], Manassas, Va.) was
additionally supplemented with 10 IU of recombinant human IL-2 (rhIL-2;
Roche, Basel, Switzerland) per ml. The bovine kidney cell lines MDBK (ATCC) and BKK (Bayer AG), as well as the monkey kidney cell line Vero
(ATCC), were cultured in Dulbecco's modified Eagle's medium supplemented with 5% (vol/vol) fetal calf serum, 100 IU of penicillin per ml, and 0.1 mg of streptomycin sulfate per ml.
Viruses.
The immunomodulator Baypamun served as the source
of iPPOV. Baypamun was produced by growing PPOV strain D1701 in bovine
kidney cells and titrating the virus on the same cell line. After the removal of cell debris, the virus harvest was inactivated with binary
ethyleneimine and concentrated by ultrafiltration. The concentrated
bulk material was reconstituted in medium and adjusted to the nominal
product titer of 106.75 tissue culture infective doses
(TCID50)/ml. Thus, approximately 99% of the cell culture
supernatant could be substituted. For stabilization of the virus
preparation, 25 mg of Polygeline per ml was added before
lyophilization. Cell culture supernatant from mock-infected bovine
kidney cells, treated in the same manner as the virus preparation,
served as negative control material. Both the Baypamun material and the
control material were kindly provided by Bayer AG.
FPV strain HP-1 (Pind Avi) and MVA preparations were generous gifts
from A. Mayr (Veterinary Faculty, University of Munich, Munich,
Germany). Both virus preparations were produced and inactivated as
previously described (19). Briefly, FPV-infected chicken embryo fibroblasts and MVA-infected Vero cells were harvested when the
cytopathic effect was 100% (3 to 5 days postinfection). The viruses
were liberated from the cells by freezing-thawing and sonication,
followed by low-speed centrifugation to remove cellular debris. After
determination of the virus titers (FPV, 108.5
TCID50/ml; MVA, 107.5 TCID50/ml),
the preparations were inactivated with
-propriolactone (Boehringer
Ingelheim, Ingelheim, Germany), stabilized with gelatin (2.5%
[wt/vol]), and lyophilized in 1-ml aliquots. Mock-infected chicken
embryo fibroblasts and Vero cells treated in the same manner as the
virus preparations served as negative controls. Before use, virus
stocks and controls were dialyzed for 48 h to eliminate any
possible toxic effects due to residual
-propriolactone.
Vaccinia virus Lister, originally obtained from the ATCC, was grown and
titrated on BKK cells as described above. Vaccinia viruses Kopenhagen
and Tian Tan, parapox bovis virus I, and wild-type PPOV were provided
by M. Büttner (Federal Research Centre for Virus Diseases of
Animals) and propagated and titrated on Vero cells as described above.
Before heat inactivation (56°C, 30 min), the titers of these virus
stocks ranged between 107 and 108
TCID50/ml. Preparations of mock-infected cells treated in a
manner similar to that used for the respective poxviruses served as controls.
Inactivation of all virus preparations was verified by assessment of
the TCID50 after 7 days of culturing. Whereas binary ethyleneimine- and
-propriolactone-inactivated viruses showed no
residual infectivity (TCID50, <101/ml),
heat-inactivated virus preparations retained residual infectivity ranging between 101 and 103
TCID50/ml. Heat-inactivated classical swine fever virus
(CSFV) and
-propriolactone-inactivated pseudorabies virus (PRV) and foot-and-mouth-disease virus (FMDV) served as controls; these were
produced in our own laboratory.
MAbs and antisera.
Murine monoclonal antibodies (MAbs)
against porcine CD4 (MAb 74-12-4; immunoglobulin G2b [IgG2b]
[26]) and major histocompatibility complex (MHC) class
II (MHCII) (SLA-DR; MAb MSA3; IgG2b [12]) were
received from J. K. Lunney (Agricultural Research Service, U.S.
Department of Agriculture, Beltsville, Md.). A murine MAb against CD25
(MAb K231-3B2; IgG1 [4]), recognizing an epitope of
the IL-2 receptor-
-chain expressed only on activated lymphocytes, was provided by C. R. Stokes (Department of Veterinary Medicine, University of Bristol, Bristol, United Kingdom). Murine MAb G47 and
rabbit antiserum no. 652, specific for porcine IFN-
, and a murine
MAb against porcine IFN-
were generous gifts from B. Charley and C. LaBonnadiere (Institut National de la Recherche Agronomique,
Jouy-en-Josas, France).
Lymphocyte proliferation assays.
Poxvirus-induced
stimulation of PBMC was achieved by incubation of 2 × 105 PBMC/well with inactivated poxviruses in a final volume
of 200 µl. The number of added inactivated virus particles depended
on the optimal stimulating capacity of each poxvirus lot and ranged between 2 × 105 TCID50 (measured before
inactivation) for iFPV and 5 × 104 TCID50
for iPPOV. After 7 days of culturing, cells were pulsed with 1 µCi of
3H-thymidine (ICN Biomedicals GmbH, Eschwege, Germany) per
microculture for 18 h; cells were then harvested onto glass fiber
filters, which were analyzed in a scintillation counter as described
previously (30). Results were expressed as mean counts per
minute of triplicate cultures or as a stimulation index (SI),
calculated as follows: SI = mean of inactivated-poxvirus-specific
proliferation/mean of spontaneous proliferation. An SI of >2 was
considered positive.
Cytolytic assays.
For the quantification of spontaneous
cytolytic activity, PBMC (105/well) were treated with
inactivated poxviruses, mock-infected cell culture supernatant, or 25 IU of rhIL-2 and then cultured with 51Cr-labeled K562 cells
(103/well) for 18 h. The percent specific cytolytic
activity was calculated as described previously (28).
Measurement of phagocytosis and the oxidative burst.
For the
investigation of poxvirus-induced phagocytosis or oxidative burst, 100 µl of heparinized blood was incubated with 100 µl of poxvirus
suspension (TCID50, 0.5 × 105 to 2 × 105, depending on the virus strain) for 30 min at
37°C. Phagocytosis and the oxidative burst were measured with
commercial available test kits (Phagoburst and Phagotest; Orpegen
Pharma, Heidelberg, Germany) according to the manufacturer's instructions.
Measurement of cytokine secretion.
The content of IL-2,
IFN-
, and IFN-
in either supernatants of poxvirus-stimulated PBMC
(2 × 105/well) or CD4-defined, separated cell
fractions collected at various times was measured.
IL-2 production was assayed by the capacity of supernatants to support
the proliferation of the IL-2-dependent cell line HT-2.
IFN-
secretion as determined by an indirect plaque reduction
bioassay as described previously (27). Briefly, the
antiviral activity of IFN-
was quantified by the reduction of
vesicular stomatitis virus-induced cytopathic effect on MDBK cells
after preincubation of the cell line with a serial dilution of
supernatants from poxvirus-stimulated PBMC. The assay was calibrated
with an internal laboratory standard of recombinant porcine IFN-
(generous gift of C. LaBonnadiere, Institut National de la Recherche
Agronomique) that was equivalent to 50 IU of recombinant human IFN-
.
Specificity was conferred by blocking with an MAb against porcine
IFN-
.
IFN-
production was quantified by an enzyme-linked immunosorbent
assay (ELISA) using an MAb and an antiserum specific for porcine
IFN-
. Cytokine concentrations were calculated using the linear
portion of the curve obtained with recombinant standards run on each
ELISA plate and were expressed in nanograms per milliliter.
Multicolor flow cytometric analysis.
For determination of
the poxvirus-stimulated cell fraction, PBMC (4 × 106)
were cultured with inactivated poxviruses (106
TCID50) for 9 days in six-well plates. After quantification
of the total cell number by trypan blue exclusion, cells were stained with an MAb against CD4 (IgG2b) in combination with an anti-CD25 (IgG1)
or an anti-MHCII (IgG2a) antibody, followed by labeling with
isotype-specific antisera (fluorescein isothiocyanate
[FITC]-conjugated anti-IgG2b, phycoerythrin [PE]-conjugated
anti-IgG1, or PE-conjugated anti-IgG2a; Southern Biotechnology
Associates, Birmingham, Ala.). All measurements were obtained with a
dual-LASER FACStar plus (Becton Dickinson, Mountain View, Calif.) as
described previously (29). Relative cell numbers of the
single-cell fractions were converted into absolute cell numbers by use
of the total cell number.
The list mode data were processed using PC-lysis and Corel draw software.
Cell sorting.
For determination of the major
cytokine-secreting cell fraction in response to iPPOV, PBMC were
separated into CD4-defined lymphocyte fractions as described previously
(30). In brief, PBMC were stained in four 20-min incubation
steps with an MAb against CD4, biotinylated goat anti-mouse
immunoglobulin (Jackson Laboratories), FITC-conjugated streptavidin
(Jackson Laboratories), and biotinylated magnetic beads (Miltenyi
Biotec, Bergisch Gladbach, Germany) on ice. They were then passed over
magnetic cell separation columns to retain the bead-coated
CD4+ cells. The bound cells were eluted by removing the
magnet. The purity of the CD4+ and CD4
cell
fractions was verified by fluorescence-activated cell sorting (FACS)
analysis (CD4+, 90%; CD4
, 99.8%).
 |
RESULTS |
Influence of iPPOV on cells assigned to the innate immune
system.
Previous studies suggested that poxvirus-mediated
activation of innate immune reactions is responsible for the
observed immunostimulating capacity (18, 19).
Consequently, our investigations of poxvirus-induced immunostimulating
effects began by analyzing the influence of iPPOV on the cytolytic
activity of NK cells and phagocytosis by monocytes and granulocytes.
The cytolytic activity of NK cells was determined by an 18-h
51Cr release assay using 51Cr-labeled K562
cells as target cells. Table 1 shows the
reactivity of 1 out of 10 tested animals and the influence of iPPOV on
NK cell cytolytic activity at an effector-to-target ratio of 100:1. Compared to spontaneous lysis, no increased lysis of K562 cells could
be seen in any of the cultures that were supplemented with different
numbers of iPPOV particles for the duration of the assay. Similarly, no
response could be found for any animal when cells were cultured with an
inactivated cell culture supernatant derived from mock-infected BKK
cells. In contrast, the addition of rhIL-2 enhanced spontaneous
cytolytic activity to 72% (Table 1, positive control). From nine more
animals, the spontaneous lysis of iPPOV-stimulated PBMC was comparable
to control spontaneous lysis, ranging from 25 to 62%. Together, these
results provide evidence that iPPOV has no capacity to enhance porcine
NK cell cytolytic activity.
In order to study the influence of iPPOV on the phagocytosis of
neutrophils and monocytes, heparinized porcine blood was incubated for
30 min with iPPOV, mock-infected cell culture supernatant, phosphate-buffered saline, or pooled swine serum. Thereafter, the
uptake of FITC-labeled Escherichia coli was quantified by flow cytometry. A typical example of the results obtained is presented in Table 1 for one animal. From these data it can be seen that independent of the number of added particles, iPPOV failed to enhance
the rate of phagocytosis over that obtained with phosphate-buffered saline or mock-infected cell culture supernatant. Only in the presence
of pooled swine serum, serving as a positive control, was the uptake of
bacteria increased by 14%. The data presented could be reproduced with
nine more animals (spontaneous phagocytosis, 8 to 24%). This result
indicated that iPPOV possessed no capacity to modulate the phagocytic
uptake of E. coli by monocytes or granulocytes.
This finding was further confirmed by analysis of the oxidative burst,
which follows the phagocytic uptake of antigen (24). The
studies were performed in a manner similar to that used for the
phagocytosis assays, with the exceptions that the oxidation of the
fluorogenic substrate dihydrorhodamine by reactive O2
metabolites was analyzed and phorbol myristate acetate (PMA) served as
a positive control. For the experiments, heparinized blood was
supplemented with iPPOV or the respective controls for 30 min before
opsonized E. coli bacteria were added for another 10 min to
induce the oxidative burst. The results obtained with blood cells from
1 out of 10 tested animals are presented in Table 1 as a typical
example. These data show that opsonized E. coli bacteria can
trigger an oxidative burst in a certain percentage of the cells,
increasing from less than 10% to approximately 40%. The addition of
different numbers of iPPOV particle led to a slight decrease, whereas
preincubation of the samples with PMA increased the induction of
reactive O2 metabolites by an additional 8%. The fact that
iPPOV did not show any costimulatory influence on an E. coli-induced oxidative burst supports the finding that iPPOV has
no apparent stimulating influence on porcine leukocyte phagocytosis.
Taken together, these functional analyses indicate that
iPPOV possesses the capacity neither to modify porcine NK
cell cytolytic activity nor to increase the phagocytic uptake or
release of reactive O2 metabolites by porcine neutrophils
and monocytes. An iPPOV-induced modulation of innate immune
reactions being responsible for the observed immunostimulating property
therefore seems to be unlikely.
iPPOV-induced proliferation of porcine PBMC.
With regard
to the fact that iPPOV apparently had no immunostimulating
influence on innate immune reactions in swine, it was surprising to
find morphological changes in resting non-poxvirus-primed PBMC upon
cultivation with iPPOV. As early as 1 day after the beginning of
stimulation, the formation of small clusters involving approximately
25% of the PBMC was observed. This characteristic property of
activated cells could not be detected in cultures incubated without
iPPOV. By day 9, the proportion of clustering cells had increased,
as had both the number of cells in the clusters and the number of
clusters (Fig. 1B). In contrast, only
minimal aggregation could be detected for the adherent cells of the
control cultures (Fig. 1A).

View larger version (80K):
[in this window]
[in a new window]
|
FIG. 1.
iPPOV-induced cell aggregation by porcine PBMC. PBMC
(4 × 106) were cultured for 9 days with iPPOV
(106 TCID50) (B) or inactivated cell culture
supernatant of mock-infected BKK cells (diluted 1:2) (A). Cells were
cultured in a final volume of 3 ml of cell culture medium in six-well
plates. Magnification, ~×46.
|
|
This microscopic finding was evidence for an activation of PBMC.
Consequently, the proliferation of PBMC was analyzed. With resting
porcine PBMC, an increase in proliferation of up to 10-fold was
detected in the presence of iPPOV, compared to spontaneous proliferation or proliferation after the addition of a cell culture supernatant from mock-infected BKK cells. As illustrated in Fig. 2A, this response was dependent on the
number of added virus particles, the highest 3H-thymidine
incorporation being obtained at a ratio of 0.1 iPPOV particle per
lymphocyte. In further assays, the time course of proliferation was
analyzed, as was the heterogeneity of the response within a larger
animal population. The proliferative response of PBMC usually started 2 to 3 days after iPPOV stimulation, reaching its maximum as late as
7 to 8 days (Fig. 2B). PBMC from 50 tested animals all showed increased
reactivity in response to cultivation with iPPOV. However, by
analysis of SIs, which ranged between 2 and 28, with an average of
approximately 5 (Fig. 2C), a rather heterogeneous response to iPPOV
became apparent. This result indicated that not all animals responded
equally to iPPOV stimulation.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 2.
iPPOV-dependent proliferation of porcine PBMC. PBMC
(2 × 105 cells/well) were cultured with iPPOV
(closed circles), inactivated cell culture supernatant from
mock-infected BKK cells (open squares), or medium (broken line). The
proliferative response of the microcultures was quantified by
3H-thymidine incorporation. The standard deviation of
triplicate cultures in single experiments is indicated by error bars.
(A) Dose-response curve after 7 days of cultivation. (B) Time course of
iPPOV stimulation (5 × 104 TCID50).
(C) SI of iPPOV-stimulated PBMC (5 × 104
TCID50) derived from 50 animals.
|
|
Identification of iPPOV-responding porcine PBMC.
The
phenotype of the activated lymphoblasts was identified by flow
cytometric analyses. For this purpose, PBMC were cultured for 9 days in
the presence of iPPOV or inactivated cell culture supernatant from
mock-infected cells. After determination of the absolute cell numbers
in the respective cultures, cells were stained with an MAb against CD4
in combination with an MAb against CD25 or MHCII (MAb directed against
SLA-DR). In agreement with the microscopic findings, the dot plots in
Fig. 3A and B) illustrated that
iPPOV-stimulated PBMC contained a significantly higher proportion of activated cells. These were characterized by increased size (high
forward scatter) and granularity (high side scatter) (Fig. 3B) (35%)
compared with the results for the control (Fig. 3A) (14%). The
majority of these iPPOV-activated cells (Fig. 3B) (35%) were
T-helper cells with a high CD4 surface antigen density, expressing the
activation marker CD25 and surface MHCII molecules (Fig. 3E and H).
Resting PBMC cultured in the presence of iPPOV (Fig. 3B) (65%)
contained only a minor proportion of CD4low T-helper cells
and were characterized by almost no expression of CD25 and MHCII
molecules (data not shown). In view of this antigen expression pattern,
resting iPPOV-cultured PBMC strongly resembled cells from the
control (Fig. 3C and F).

View larger version (47K):
[in this window]
[in a new window]
|
FIG. 3.
Phenotypic identification of the iPPOV-responding
cell fraction. PBMC were cultured in the presence of iPPOV or cell
culture supernatant from mock-infected BKK cells for 9 days as
described in the legend to Fig. 2. (A and B) In the dot plots of
forward scatter (FSC) versus side scatter (SSC) (A and B), the size and
granularity of both cell cultures are shown. The selective analysis of
nonactivated PBMC and PBMC activated with iPPOV (B) was achieved by
setting electronic windows on cells with low FSC and SSC (65%) or high
FSC and SSC (35%). (C to H) Contour plots of expression of CD4 versus
CD25 (C to E) and CD4 versus MHCII (F to H) for all mock-cultured cells
(C and F), all iPPOV-cultured cells (D and G), and the
iPPOV-activated cell population (E and H). Numbers in the corners
of the contour plots indicate percentages of cells.
|
|
A comparison was made of the relative cell numbers in all
iPPOV-stimulated PBMC and all mock-cultured PBMC. This result
showed that iPPOV-stimulated cells had an approximately threefold
increase in CD25+ T-helper cells (24 versus 9%) and a
fourfold increase in MHCII-positive T-helper cells (36 versus 9%)
compared with the T-helper cells from the control. The increased
proportion of activated T-helper cells was due both to the death of
other cells in the culture over time and to a threefold absolute
increase in the CD4+ cell numbers compared to those in the
control (control, 8.89 × 104/ml of T-helper cells;
iPPOV, 21.26 × 104/ml of T-helper cells). These
experiments were repeated with PBMC from nine more animals, all showing
a two- to fourfold absolute increase in T-helper-cell numbers upon
iPPOV stimulation compared to the results obtained with cultivation
with mock-infected cell culture supernatant (data not shown). Together,
these experiments demonstrate that mainly T-helper cells responded to
stimulation with iPPOV.
Functional characterization of the iPPOV-responding cell
fraction.
Functional analysis of the effector cells generated upon
activation of PBMC with iPPOV should contribute to the elucidation of the basic mechanism responsible for the stimulation of the immune
system. In this context, analyses focused particularly on the secretion
of the cytokines IL-2, IFN-
, and IFN-
, because they play an
important role in the response against infectious agents. As shown in
Fig. 4, it was possible to detect
increased concentrations of all tested cytokines in cell culture
supernatants from iPPOV-stimulated PBMC. Inactivated control
supernatants from mock-infected cells had no effect. When the time
course of the induced reactions was monitored, increased secretion of
IFN-
measured after the first day of stimulation was the earliest
detectable event (Fig. 4A). Thereafter, maximal IL-2 release at day 3 and maximal IFN-
and IFN-
release at day 5 were detected. In
combination with the observed maximal proliferation at day 7 (Fig. 2B),
the results were indicative of the classical pathway of T-helper-cell activation and differentiation. The analyses of cytokine production could be reproduced with PBMC from nine more animals, with similar heterogeneous reactivities, as already described for proliferation. Compared to the data for the control supernatants, a 2- to 10-fold increase in the levels of all cytokines was detected (data not shown).

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 4.
Kinetics of iPPOV-induced cytokine release. Cytokine
release time courses for PBMC cultured in the presence of iPPOV
(5 × 104 TCID50) (closed circles),
inactivated cell culture supernatant from mock-infected BKK cells
(diluted 1:2) (open squares), or medium (broken line). Results are
shown for one representative animal. The standard deviation of
triplicate cultures in single experiments was less than 10%. At
different times, supernatants were collected. The IFN- antiviral
activity in the supernatants was calculated by determination of
dilutions causing a 50% reduction of the vesicular stomatitis
virus-induced cytopathic effect in MDBK cells. The IL-2 concentration
was measured by a bioassay using the IL-2-dependent cell line HT-2. The
IFN- concentration was quantified by an ELISA.
|
|
By iPPOV stimulation of immunomagnetically sorted CD4+
and CD4
cells, it was possible to show that
CD4+ cells, as the main iPPOV-responding cell fraction,
were also the major source for the secreted cytokines. In these
experiments, the amount of IL-2 secreted by the iPPOV-stimulated
CD4+ cell fraction was twice that of the CD4
cell fraction (58 × 103 cpm versus 28 × 103 cpm). The amount of IFN-
secreted by the
CD4+ T cells was increased nearly threefold (196 versus 75 ng/ml), and that of IFN-
was increased up to fourfold (320 versus 80 experimental units [EU] of IFN-
/ml). In summary, these data
indicated that the stimulating capacity of iPPOV is effected
primarily through the activation of T-helper cells, which in turn
secrete important immunomodulatory cytokines.
Investigation of the stimulating capacities of inactivated
poxviruses other than iPPOV.
The experiments described so far
were performed with iPPOV. However, the finding that iFPV and iMVA
may also have immunostimulating effects (5, 10) suggested
that the capacity to stimulate the porcine immune system represents a
property common to all poxviruses. We therefore analyzed the reactivity
of porcine PBMC to seven more poxvirus strains belonging to the genera
Orthopoxvirus, Avipoxvirus, and
Parapoxvirus. In order to exclude inhibitory effects caused
by the secretion of viral immunomodulating proteins, such as soluble
receptors for IFN-
/
, IFN-
, and TNF-
, the experiments were
performed only with heat- or
-propriolactone-inactivated viruses. As
shown in Fig. 5, all tested poxviruses
were capable of enhancing the proliferative response of PBMC compared
to spontaneous proliferation, whereas inactivated cell culture
supernatants from mock-infected cells or other tested viruses (PRV,
FMDV, CSFV) had no effect. The optimal SI of the poxviruses, as
determined with PBMC from the same animal, ranged between 2.5 and 5. This result indicated that only minor differences existed in the
stimulating capacities of the different poxviruses.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 5.
Proliferative response of porcine PBMC upon stimulation
with different inactivated poxvirus strains. PBMC (2 × 105 cells/well) were cultured with different poxvirus
strains (orthopoxviruses and parapoxviruses, 0.5 × 105 to 1 × 105 TCID50;
avipoxvirus, 2 × 105 TCID50), other
viruses (PRV, 105 TCID50; similar results were
obtained with FMDV and CSFV), the respective controls, or medium alone.
After 7 days, proliferation was determined by measurement of
3H-thymidine incorporation. The data presented show the SI
of poxvirus-stimulated (black bars) or mock-cultured (white bars) PBMC
in comparison with spontaneous proliferation (broken line). The
standard deviation of triplicate cultures in single experiments is
indicated by error bars.
|
|
Clearly, the proliferative response of PBMC upon iPPOV stimulation
was caused mainly by the activation of T-helper cells. It appeared that
the proliferative response of PBMC against other poxviruses might also
be based primarily on the stimulation of T-helper cells. In order to
directly prove this hypothesis, we repeated the iPPOV experiments
with one member of each tested poxvirus genus. Like the data obtained
with iPPOV, the experiments shown in Fig.
6 indicate that iFPV and iMVA failed to
influence NK cell activity and phagocytosis, whereas both viruses were
capable of increasing IFN-
, IL-2, and IFN-
secretion and cell
proliferation. All experiments were performed with PBMC from 10 animals, and the mean SI (or the mean concentration, if no effect was
detectable within the medium controls) was calculated for each
poxvirus. The approximately fourfold-increased reaction in response to
each poxvirus (Fig. 6) supports the finding that different virus
genera showed no significant differences in their capacities to
induce immunostimulatory effects. Further flow cytometric
analyses identified T-helper cells as the main reacting cell
fraction in response to iMVA and iFPV (data not shown). It may thus be
concluded that the capacity to stimulate the immune system is not
specific for the Parapoxvirus genus but may also be observed
in virus strains of other poxvirus genera. The basic mechanism
responsible for the immunostimulatory effects seems to be the same for
all poxviruses.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 6.
Comparison of the immunostimulating capacities of
different inactivated poxviruses. The influence of iFPV (2 × 105 TCID50), iMVA (1 × 105
TCID50) iPPOV (5 × 104
TCID50), and FMDV (other virus; 1 × 106
TCID50) on NK cell activity and phagocytosis was determined
as described in the text. The concentrations of IFN- , IL-2, and
IFN- in cell culture supernatants and the proliferation of PBMC
(2 × 105/well) were quantified as described in the
legend to Fig. 4. The data presented show the mean SI relative to the
control (or the mean concentrations if no effect was detectable within
the medium control) and the means ± standard deviations for PBMC
from 10 tested animals. Different inactivated poxviruses are indicated
as black bars; controls are indicated as white bars.
|
|
 |
DISCUSSION |
As shown in several in vivo studies, the prophylactic application
of iPPOV can strengthen host immune defense, resulting in reduced susceptibility to invading pathogens (6, 16, 33, 39). In agreement with earlier in vitro studies (5,
18), we showed that this immunostimulating capacity is not
iPPOV specific but is common to poxviruses of different genera.
Considering that poxviruses are widely used as vectors in vaccine
development, it seems surprising that only a few studies exist on this
immunostimulating property. One reason might be the synthesis of viral
immunomodulating proteins, such as soluble receptors for IFN-
/
,
IFN-
, and TNF-
, at early times during poxvirus (vector)
infections (25). These secreted proteins may in turn impair
the immunological response against the poxvirus vectors. This
hypothesis is supported by the reported finding that inactivated but
not infectious vaccinia viruses may induce IFN-
production in bovine
or porcine PBMC (6). In contrast, the addition of MVA, which
lacks the respective immunomodulatory genes and is not permissive for
porcine and bovine PBMC, induces the secretion of high levels of
IFN-
(6). Thus, the detection of immunostimulating
properties might be expected only if poxviruses are inactivated or
their genome is deficient in the respective immunomodulating genes.
On the basis of investigations of the basic mechanism for the
immunostimulating capacity of poxviruses, it was suggested that poxvirus-mediated activation of innate immune reactions was responsible for the observed immunostimulating capacity (18, 19). This assumption was supported by earlier studies revealing increased phagocytosis and oxidative burst in rats and humans and increased NK
cell activity in mice under the influence of iFPV, iMVA, and iPPOV
(10, 19). When we analyzed the reaction of porcine PBMC to
inactivated poxviruses from different genera, no such early detectable
reactions could be found. We believe that the different results seen
within the innate immune system may be due to the different species
involved or to different experimental approaches. Unlike investigators
in former studies (10), we did not isolate phagocytes for
the phagocytosis assays, so that any preactivation of these cells
during the course of the isolation process (as described in the
literature) could be ruled out (8, 9). The poxvirus-induced
secretion of inflammatory cytokines, such as TNF-
and
granulocyte-macrophage colony-stimulating factor, which can function as
costimulatory signals for preactivated (isolated) phagocytes, was
minimized by reduction of the experimental incubation time from up to
4 h (10) to 30 min. Similarly, incubation times in the
NK cell assays were kept as short as possible to avoid indirect
stimulation of NK cells, e.g., by cytokine secretion. Taken together,
our experiments gave no evidence for direct poxvirus-induced stimulation of innate immune reactions in swine.
While former studies have focused only on early detectable
poxvirus-induced effects (until day 2) (5, 10, 18), the experiments presented here included investigations of late observable effects (until day 9). This difference might explain the finding that
mainly T-helper cells responded to stimulation by inactivated poxviruses. The question arises as to how specific T cells might be
stimulated by poxviruses in an in vitro culture system. A secondary (memory) response seems unlikely, because our studies were performed exclusively with PBMC from non-poxvirus-treated (unprimed) animals. However, it may be considered that memory T-helper cells previously primed to unrelated but poxvirus-cross-reactive antigens responded to
activation with the poxviruses. A primary poxvirus-specific immune
response also appears to be unusual. Nevertheless, it might be possible
that the extensive immunogenic properties of poxviruses could have
increased the frequency of reacting T cells, resulting in a measurable
primary response, even in an in vitro system. In any case, further
experiments are needed to answer this question.
In this study, T-helper cells were identified not only as the main
activated and proliferating cell fraction but also as the major source
of the increased levels of IL-2, IFN-
, and IFN-
All three
secreted cytokines have important antiviral and immunomodulatory functions (3, 31). In consequence, their usage as
therapeutic agents in cancer research and in the treatment of viral
infectious diseases or autoimmune diseases is becoming more attractive
(7, 14, 31). It is thus understandable that increased
poxvirus-induced secretion of these cytokines also might prove
therapeutically beneficial. It might even be considered a basic
mechanism for the finding that animals pretreated with poxviruses had
reduced susceptibility or milder symptoms and more rapid recovery from infectious diseases than the respective, untreated control animals (33, 39). Poxvirus-preactivated T-helper cells might promote the enhanced secretion of cytokines during the development of a
specific host defense against an unrelated antigen. Additionally, the
possibility cannot be ruled out that other important immunomodulatory cytokines might be secreted by lymphocytes during stimulation with
inactivated poxviruses. Genes encoding soluble, viral receptors for
TNF-
, IL-1
, or different chemokines (25) indicate the importance of these cytokines, at least within poxvirus infections.
The late onset of poxvirus-induced cytokine release follows the pattern
of typical T-helper-cell activation and differentiation. With regard to
IFN-
secretion, it provides further evidence for a cell-mediated
immune reaction, at least in part, in response to stimulation with
inactivated poxviruses. At the same time, it explains why only a
prophylactic or metaphylactic application of inactivated poxviruses
provides efficiently reduced susceptibility to infectious diseases,
whereas a therapeutic application has almost no effect (16).
It is likely that a minimum of 5 days is required to create an
effective barrier against invading pathogens by poxvirus-mediated
T-helper-cell activation and cytokine secretion. Consequently, it is
understandable that a therapeutic application of inactivated poxviruses
would take place later than the development of a specific immune
response against an unrelated antigen.
In summary, the results presented here indicate that iPPOV
primarily stimulates cells of the specific immune system. T-helper cells were identified as the main activated and cytokine-secreting cell
fraction. Moreover, other poxviruses seem capable of stimulating T-helper cells by the same mechanism, providing evidence that all
tested poxviruses possess similar stimulating capacities. Further
studies are required to determine whether this stimulating property
seen in vitro relates to the increased protection against infectious
diseases observed in vivo.
 |
ACKNOWLEDGMENTS |
We thank A. Mayr and M. Büttner for generously supplying
inactivated poxviruses and K. McCullough and B. Ober for critical review of the manuscript.
This work was supported by R&D/BIO Research, Bayer AG Animal Health,
Leverkusen, Germany.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institute of
Immunology, Federal Research Centre for Virus Diseases of Animals,
Paul-Ehrlich-Str. 28, D-72076 Tübingen, Germany. Phone:
49-7071-967-256. Fax: 49-7071-967-303. E-mail:
armin.saalmueller{at}tue.bfav.de.
 |
REFERENCES |
| 1.
|
Alcami, A., and G. L. Smith.
1992.
A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection.
Cell
71:153-167[CrossRef][Medline].
|
| 2.
|
Antoine, G.,
F. Scheiflinger,
F. Dorner, and F. G. Falkner.
1998.
The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses.
Virology
244:365-396[CrossRef][Medline].
|
| 3.
|
Bach, E. A.,
M. Aguet, and R. D. Schreiber.
1997.
The IFN gamma receptor: a paradigm for cytokine receptor signaling.
Annu. Rev. Immunol.
15:563-591[CrossRef][Medline].
|
| 4.
|
Bailey, M.,
K. Stevens,
P. W. Bland, and C. R. Stokes.
1992.
A monoclonal antibody recognising an epitope associated with pig interleukin-2 receptors.
J. Immunol. Methods
153:85-91[CrossRef][Medline].
|
| 5.
|
Büttner, M.,
C. P. Czerny,
K. H. Lehner, and K. Wertz.
1995.
Interferon induction in peripheral blood mononuclear leukocytes of man and farm animals by poxvirus vector candidates and some poxvirus constructs.
Vet. Immunol. Immunopathol.
46:237-250[CrossRef][Medline].
|
| 6.
|
Castrucci, G.,
F. Frigeri,
B. I. Osburn,
M. Ferrari,
F. Barreca, and D. Salvatori.
1998.
Further investigations on the efficacy of a non-specific defence inducer evaluated in calves exposed to infectious bovine rhinotracheitis virus.
Comp. Immunol. Microbiol. Infect. Dis.
21:155-163[CrossRef][Medline].
|
| 7.
|
Clark, J. I.,
E. R. Gaynor,
B. Martone,
S. C. Budds,
R. Manjunath,
R. C. Flanigan,
W. B. Waters, and J. A. Sosman.
1999.
Daily subcutaneous ultra-low-dose interleukin 2 with daily low-dose interferon-alpha in patients with advanced renal cell carcinoma.
Clin. Cancer Res.
5:2374-2380[Abstract/Free Full Text].
|
| 8.
|
Elbim, C.,
S. Bailly,
S. Chollet-Martin,
J. Hakim, and M. A. Gougerot-Pocidalo.
1994.
Differential priming effects of proinflammatory cytokines on human neutrophil oxidative burst in response to bacterial N-formyl peptides.
Infect. Immun.
62:2195-2201[Abstract/Free Full Text].
|
| 9.
|
Elbim, C.,
S. Chollet-Martin,
S. Bailly,
J. Hakim, and M. A. Gougerot-Pocidalo.
1993.
Priming of polymorphonuclear neutrophils by tumor necrosis factor alpha in whole blood: identification of two polymorphonuclear neutrophil subpopulations in response to formyl-peptides.
Blood
82:633-640[Abstract/Free Full Text].
|
| 10.
|
Förster, R.,
G. Wolf, and A. Mayr.
1994.
Highly attenuated poxviruses induce functional priming of neutrophils in vitro.
Arch. Virol.
136:219-226[CrossRef][Medline].
|
| 11.
|
Graham, K. A.,
A. S. Lalani,
J. L. Macen,
T. L. Ness,
M. Barry,
L. Y. Liu,
A. Lucas,
I. Clark-Lewis,
R. W. Moyer, and G. McFadden.
1997.
The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues.
Virology
229:12-24[CrossRef][Medline].
|
| 12.
|
Hammerberg, C., and G. G. Schurig.
1986.
Characterization of monoclonal antibodies directed against swine leukocytes.
Vet. Immunol. Immunopathol.
11:107-121[CrossRef][Medline].
|
| 13.
|
Hammerl, J.,
G. Wolf, and H. Berner.
1995.
Klinische Untersuchungen zur Wirkung des Paramunitätsinducers Baypamun als Prophylaxe beim MMA-Komplex der Sau.
Tieraerztl. Umsch.
50:383-386.
|
| 14.
|
Harris, D. T.,
G. R. Matyas,
L. G. Gomella,
E. Talor,
M. D. Winship,
L. E. Spitler, and M. J. Mastrangelo.
1999.
Immunologic approaches to the treatment of prostate cancer.
Semin. Oncol.
26:439-447[Medline].
|
| 15.
|
Huang, S.,
W. Hendriks,
A. Althage,
S. Hemmi,
H. Bluethmann,
R. Kamijo,
J. Vilcek,
R. M. Zinkernagel, and M. Aguet.
1993.
Immune response in mice that lack the interferon-gamma receptor.
Science
259:1742-1745[Abstract/Free Full Text].
|
| 16.
|
Kyriakis, S. C.,
E. D. Tzika,
D. N. Lyras,
A. C. Tsinas,
K. Saoulidis, and K. Sarris.
1998.
Effect of an inactivated Parapoxvirus based immunomodulator (Baypamun) on post weaning diarrhoea syndrome and wasting pig syndrome of piglets.
Res. Vet. Sci.
64:187-190[CrossRef][Medline].
|
| 17.
|
Marsig, E., and H. Stickl.
1988.
The effectiveness of immunomodulators from microorganisms and of animal pox preparations against tumor cell lines in vitro.
Zentbl. Veterinaermed.
35:601-609.
|
| 18.
|
Mayr, A.,
M. Büttner,
S. Pawlas,
V. Erfle,
B. Mayr,
R. Brunner, and K. Osterkorn.
1986.
Comparative studies of the immunostimulating (paramunizing) effectiveness of BCG, levamisole, Corynebacterium parvum and preparations of pox viruses in various in vivo and in vitro tests.
Zentbl. Veterinaermed.
33:321-339.
|
| 19.
|
Mayr, A.,
M. Büttner,
G. Wolf,
H. Meyer, and C. Czerny.
1989.
Experimental detection of the paraspecific effects of purified and inactivated poxviruses.
Zentbl. Veterinaermed.
36:81-99.
|
| 20.
|
Mayr, A.,
M. Herlyn,
H. Mahnel,
A. Danco,
A. Zach, and H. Bostedt.
1981.
Bekämpfung des Ecthyma contagiosum (Pustulardermatitis) der Schafe mit einem neuen Parenteral-Zellkultur-Lebendimpfstoff.
Zentbl. Veterinaermed.
28:535-552.
|
| 21.
|
Mayr, A.,
B. Himmer,
G. Baljer, and J. Sailer.
1978.
Erregerunspezifische Prophylaxe und Therapie von Pseudomonas-aeruginosa-Wundinfektion mittels Paramunisierung im Mäusemodell.
Zentbl. Bakteriol. Hyg. Parasitenkd. Infektionskr. Abt. 1 Orig. Reihe A
176:506-514.
|
| 22.
|
Meyer, H.,
G. Sutter, and A. Mayr.
1991.
Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence.
J. Gen. Virol.
72:1031-1038[Abstract/Free Full Text].
|
| 23.
|
Moss, B.
1996.
Poxviridae and their replication, p. 2079-2111.
In
B. N. Fields, D. M. Knipe, and P. Howley (ed.), Virology. Lippincott-Raven, Philadelphia, Pa.
|
| 24.
|
Murray, H. W., and Z. A. Cohn.
1980.
Macrophage oxygen-dependent antimicrobial activity. III. Enhanced oxidative metabolism as an expression of macrophage activation.
J. Exp. Med.
152:1596-1609[Abstract/Free Full Text].
|
| 25.
|
Nash, P.,
J. Barrett,
J. X. Cao,
S. Hota-Mitchell,
A. S. Lalani,
H. Everett,
X. M. Xu,
J. Robichaud,
S. Hnatiuk,
C. Ainslie,
B. T. Seet, and G. McFadden.
1999.
Immunomodulation by viruses: the myxoma virus story.
Immunol. Rev.
168:103-120[CrossRef][Medline].
|
| 26.
|
Pescovitz, M. D.,
J. K. Lunney, and D. H. Sachs.
1985.
Murine anti-swine T4 and T8 monoclonal antibodies: distribution and effects on proliferative and cytotoxic T cells.
J. Immunol.
134:37-44[Abstract].
|
| 27.
|
Rubinstein, S.,
P. C. Familletti, and S. Pestka.
1981.
Convenient assay for interferons.
J. Virol.
37:755-758[Abstract/Free Full Text].
|
| 28.
|
Saalmüller, A.,
W. Hirt,
S. Maurer, and E. Weiland.
1994.
Discrimination between two subsets of porcine CD8+ cytolytic T lymphocytes by the expression of CD5 antigen.
Immunology
81:578-583[Medline].
|
| 29.
|
Saalmüller, A.,
W. Hirt, and M. J. Reddehase.
1989.
Phenotypic discrimination between thymic and extrathymic CD4 CD8 and CD4+CD8+ porcine T lymphocytes.
Eur. J. Immunol.
19:2011-2016[Medline].
|
| 30.
|
Saalmüller, A., and S. Maurer.
1994.
Major histocompatibility antigen class II expressing resting porcine T lymphocytes are potent antigen-presenting cells in mixed leukocyte culture.
Immunobiology
190:23-34[Medline].
|
| 31.
|
Sen, G., and P. Lengyel.
1992.
The interferon system. A bird's eye view of its biochemistry.
J. Biol. Chem.
267:5017-5020[Free Full Text].
|
| 32.
|
Steinmassl, M., and G. Wolf.
1990.
Formation of interleukin-2 and interferon alpha by mononuclear leukocytes of swine after in vitro stimulation with different virus preparations.
Zentbl. Veterinaermed.
37:321-331.
|
| 33.
|
Strube, W.,
D. Kretzdorn,
J. Grunmach,
R. D. Bergle, and P. Thein.
1989.
The effectiveness of the paramunity inducer Baypamun (PIND-ORF) for the prevention and metaphylaxis of an experimental infection with the infectious bovine rhinotracheitis virus in cattle.
Tieraerztl. Prax.
17:267-272.
|
| 34.
|
Symons, J. A.,
A. Alcami, and G. L. Smith.
1995.
Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity.
Cell
81:551-560[CrossRef][Medline].
|
| 35.
|
Tzahar, E.,
J. D. Moyer,
H. Waterman,
E. G. Barbacci,
J. Bao,
G. Levkowitz,
M. Shelly,
S. Strano,
R. Pinkas-Kramarski,
J. H. Pierce,
G. C. Andrews, and Y. Yarden.
1998.
Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network.
EMBO J.
17:5948-5963[CrossRef][Medline].
|
| 36.
|
Upton, C.,
J. L. Macen,
M. Schreiber, and G. McFadden.
1991.
Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence.
Virology
184:370-382[Medline].
|
| 37.
|
Upton, C.,
K. Mossman, and G. McFadden.
1992.
Encoding of a homolog of the IFN-gamma receptor by myxoma virus.
Science
258:1369-1372[Abstract/Free Full Text].
|
| 38.
|
Whitton, J. L., and M. B. Oldstone.
1996.
Immune response to viruses, p. 345-374.
In
B. N. Fields, D. Knipe, and P. Howley (ed.), Virology. Lippincott-Raven, Philadelphia, Pa.
|
| 39.
|
Ziebell, K. L.,
H. Steinmann,
D. Kretzdorn,
T. Schlapp,
K. Failing, and N. Schmeer.
1997.
The use of Baypamun N in crowding associated infectious respiratory disease: efficacy of Baypamun N (freeze dried product) in 4-10 month old horses.
Zentbl. Veterinaermed.
44:529-536.
|
Journal of Virology, September 2000, p. 7943-7951, Vol. 74, No. 17
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Fischer, T., Planz, O., Stitz, L., Rziha, H.-J.
(2003). Novel Recombinant Parapoxvirus Vectors Induce Protective Humoral and Cellular Immunity against Lethal Herpesvirus Challenge Infection in Mice. J. Virol.
77: 9312-9323
[Abstract]
[Full Text]